• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

Ex-PepsiCo CEO Indra Nooyi worked from midnight until 5 a.m. as a receptionist to pay for her Yale degree—and she says ‘respect went up’ because of it

2

Shark Tank's Kevin O'Leary says if he were 25 today, he'd chase these two booming opportunities in the world of AI

3

China’s birth rate just hit its lowest point since 1949—and Trip.com cofounder James Liang thinks that’s a threat to innovation

1

Ex-PepsiCo CEO Indra Nooyi worked from midnight until 5 a.m. as a receptionist to pay for her Yale degree—and she says ‘respect went up’ because of it

2

Shark Tank's Kevin O'Leary says if he were 25 today, he'd chase these two booming opportunities in the world of AI

3

China’s birth rate just hit its lowest point since 1949—and Trip.com cofounder James Liang thinks that’s a threat to innovation
Health

Leading South African COVID scientist accuses West of racism over skeptical response to country’s Omicron research

By
David Meyer
David Meyer
Down Arrow Button Icon
By
David Meyer
David Meyer
Down Arrow Button Icon
January 21, 2022, 8:15 AM ET
Add Fortune on Google for similar content.

A senior South African scientist has accused Western nations of racism, over the way they skeptically received early data from the country showing that the Omicron variant of the novel coronavirus is relatively mild.

Shabir Madhi—professor of vaccinology at the University of the Witwatersrand, chair of the National Advisory Group on Immunization, and a top World Health Organization adviser—told the BBC that the West had at the least refused “to believe the science because it came from Africa.”

“It seems like high-income countries are much more able to absorb bad news that comes from countries like South Africa,” he said. “When we’re providing good news, all of a sudden there’s a whole lot of skepticism. I would call that racism.”

Madhi was one of the prominent South African experts telling the world in early December that Omicron was fast-spreading but had what seemed to be a low hospitalization rate. The country’s scientists continued to emit such data throughout that month, before a formal South African study—and two others from the U.K.—confirmed Omicron’s mildness. Within a couple weeks, rich countries’ leaders started talking about treating Omicron like the flu, though the WHO continues to warn against being so blasé about the variant.

Some of the early skepticism referenced the potentially confounding effects of South Africa’s relatively young population; younger people are generally less likely to get serious ill with COVID. However, Madhi pointed out that South Africans are actually more susceptible to severe disease, because of the prevalence of HIV and high obesity rates there. (Indeed, South African scientists were noting from the start that Omicron was having a milder impact on older people as well as younger.)

“Scientifically rigorous”

Salim Karim, the South African vice-president of the International Science Council, also told the BBC that “everyone was expecting the worst [about Omicron] and when they weren’t seeing it, they were questioning whether our observations were sufficiently scientifically rigorous.”

As it happens, South Africa has excellent laboratory infrastructure, largely thanks to the decades it has spent fighting HIV and tuberculosis, among other viruses and diseases.

A few months after the pandemic struck, the government tapped into this infrastructure by establishing a new network of labs, scientists and academics to sequence samples and provide scientific data in the COVID-19 fightback. A Regional Centre of Excellence for Genomic Surveillance and Bioinformatics was set up last July, to support the rapid expansion of sequencing across the whole of southern Africa.

African COVID vaccine production is already leaning heavily on South Africa, due to the advanced state of its biotech sector, though more capacity is likely to come online in Senegal this year.

South Africa’s genomic-sequencing prowess has certainly proved useful. It identified the Beta variant in late 2020 and Omicron a year later, after scientists there and in neighboring Botswana discovered the new strain at the same time. (Botswanan President Mokgweetsi Masisi subsequently said his country’s first cases were foreign diplomats who had come from Europe.)

“Vaccine apartheid”

But the reaction to these discoveries also prompted rich countries to institute travel bans on the region, decimating tourism and hammering currencies. This reaction was widely characterized as racist—and ineffective.

“When South African scientists discovered Omicron, the new variant, they immediately took on the responsibility of informing the entire world that a new variant has been found,” President Cyril Ramaphosa said last month. “And what was the response? The northern countries decided to punish the excellence from Africa. They basically said, we will not allow you to travel. Lo and behold! Omicron is spreading all over the world.”

The South African leader also slammed rich countries over their hoarding of vaccines, claiming they were fueling “vaccine apartheid”—a reference to the racist system of “separate development” that heavily oppressed South African Black people in the days of white minority rule.

“They are just giving us the crumbs from their table. The greed they demonstrated was disappointing, particularly when they say they are our partners. Because our lives in Africa are just as important as lives in Europe, North America and all over,” Ramaphosa said.

Never miss a story: Follow your favorite topics and authors to get a personalized email with the journalism that matters most to you.

About the Author
By David Meyer
LinkedIn icon
See full bioRight Arrow Button Icon
Add Fortune on Google for similar content.

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

The Best Berberine Supplements (2026): Everything You Need to Know
HealthDietary Supplements
The Best Berberine Supplements (2026): Everything You Need to Know
By Christina SnyderJuly 7, 2026
11 hours ago
‘I was one of those children’: Utah revokes license of the boarding school where Paris Hilton says she was abused
Asiautah
‘I was one of those children’: Utah revokes license of the boarding school where Paris Hilton says she was abused
By The Associated PressJuly 7, 2026
16 hours ago
Around 2.6 million fewer Americans have affordable healthcare access plan as affordability becomes top issue ahead of midterms
North AmericaAmerican Politics
Around 2.6 million fewer Americans have affordable healthcare access plan as affordability becomes top issue ahead of midterms
By The Associated Press and Ali SwensonJuly 7, 2026
16 hours ago
McConnell “continuing his recovery” after hospitalization as Senate Republicans grapple with slim majority ahead of midterms
PoliticsAmerican Politics
McConnell “continuing his recovery” after hospitalization as Senate Republicans grapple with slim majority ahead of midterms
By The Associated Press and Mary Clare JalonickJuly 7, 2026
16 hours ago
Landline phone orders spiked 277% this summer. Blame your smartphone bill
Retailsmartphones and mobile devices
Landline phone orders spiked 277% this summer. Blame your smartphone bill
By Vidhi Choudhary and Retail BrewJuly 7, 2026
17 hours ago
Despite a $220 million net worth, Rafael Nadal says he won’t retire because he hates waking up to no plans—so he’s opened a chain of hotels instead
SuccessCareers
Despite a $220 million net worth, Rafael Nadal says he won’t retire because he hates waking up to no plans—so he’s opened a chain of hotels instead
By Orianna Rosa RoyleJuly 7, 2026
24 hours ago

Most Popular

Ex-PepsiCo CEO Indra Nooyi worked from midnight until 5 a.m. as a receptionist to pay for her Yale degree—and she says ‘respect went up’ because of it
Success
Ex-PepsiCo CEO Indra Nooyi worked from midnight until 5 a.m. as a receptionist to pay for her Yale degree—and she says ‘respect went up’ because of it
By Preston ForeJuly 6, 2026
2 days ago
Shark Tank's Kevin O'Leary says if he were 25 today, he'd chase these two booming opportunities in the world of AI
AI
Shark Tank's Kevin O'Leary says if he were 25 today, he'd chase these two booming opportunities in the world of AI
By Marco Quiroz-GutierrezJuly 5, 2026
3 days ago
China’s birth rate just hit its lowest point since 1949—and Trip.com cofounder James Liang thinks that’s a threat to innovation
Asia
China’s birth rate just hit its lowest point since 1949—and Trip.com cofounder James Liang thinks that’s a threat to innovation
By Nicholas GordonJuly 7, 2026
24 hours ago
Current price of oil as of July 7, 2026
Personal Finance
Current price of oil as of July 7, 2026
By Joseph HostetlerJuly 7, 2026
18 hours ago
Despite a $220 million net worth, Rafael Nadal says he won't retire because he hates waking up to no plans—so he's opened a chain of hotels instead
Success
Despite a $220 million net worth, Rafael Nadal says he won't retire because he hates waking up to no plans—so he's opened a chain of hotels instead
By Orianna Rosa RoyleJuly 7, 2026
24 hours ago
Even as Elon Musk calls philanthropy ‘very hard,’ everyday Americans gave a record $617 billion—despite feeling the squeeze over the cost of living
Success
Even as Elon Musk calls philanthropy ‘very hard,’ everyday Americans gave a record $617 billion—despite feeling the squeeze over the cost of living
By Preston ForeJuly 4, 2026
4 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.